Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ATLAS Biolabs Participates in Two European Research Projects

Published: Thursday, October 11, 2012
Last Updated: Wednesday, October 10, 2012
Bookmark and Share
Company to investigate DNA repair and cellular aging.

ATLAS Biolabs has announced its participation in two European research projects focusing on the impact of chromatin dynamics on DNA damage (aDDRess) and the influence of DNA damage on cellular aging (CodeAge).

ATLAS Biolabs will be responsible for the analysis of the NGS data collected in both projects.

This task also includes the development of new strategies and bioinformatics tools for NGS data analysis and the identification of biomarkers of DNA damage.

The DNA in the nuclei of eukaryotic cells is tightly wrapped around histones to form chromatin, a structure subject to constant dynamic changes in the course of DNA replication and DNA repair.

In particular, a better understanding of chromatin dynamics in DNA repair would provide novel insights into the mechanisms by which the cell protects itself from DNA damage and the disturbances that cause human disease.

Moreover, by investigating the cellular responses triggered by DNA damage, it would be possible to find new approaches for preventive therapies and elucidate the process of aging.

Both the aDDRess and CodeAge projects receive funding from the FP7 Marie Curie Initial Training Network of the European Union.

The Training Network opens up career opportunities for young talents and aims to accelerate the transfer of research findings into medical applications by encouraging research collaborations between academic institutions and medium-sized commercial enterprises.

The two projects involve a total of 22 research groups in 9 different European countries.

“aDDRess and CodeAge will combine state-of-the-art knowledge in basic molecular genetics, omics technologies, translational research and clinical application. We are excited about contributing to the analysis of NGS data within both projects,” said Professor Peter Nürnberg, CEO of ATLAS Biolabs GmbH.

Professor Nürnberg continued, “I am convinced that our customers will benefit from the added competencies that we will gather from this program.”

The European research projects aDDRess and CodeAge
aDDRess (chromatin dynamics on the DNA damage response) and CodeAge (Chronic DNA damage in Ageing) are being funded for four years by the Marie Curie Initial Training Networks within the European FP7 program.

The Marie Curie Initial Training Networks are open to young researchers who want to gain experience abroad in the private sector, and to complete their training by participating in a joint European research project.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ATLAS Biolabs and Ingenuity® Systems Sign Collaboration Agreement
ATLAS Biolabs complements its bioinformatics portfolio with Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for comprehensive data analysis and interpretation.
Wednesday, June 20, 2012
ATLAS Biolabs Certified for Innovative Exome Enrichment Technology from Roche NimbleGen
New technology allows the targeted enrichment and subsequent sequencing of the human exome that carry the genetic blueprint encoding the body's proteins.
Thursday, April 14, 2011
ATLAS Biolabs has Licensed Cartagenia Software for Analysis and Interpretation of Genetic Data
ATLAS Biolabs expands its services for the evaluation of genetic data obtained by DNA chip analysis.
Friday, October 01, 2010
Scientific News
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Genes That Increase Children's Risk Of Blood Infection Identified
A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children.
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!